If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Baqsimi ® (glucagon) nasal powder3mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How to position an unconscious person following administration of Baqsimi™ (glucagon) nasal powder?
It is recommended to turn the person on their side after administering Baqsimi (glucagon) nasal powder.
If the person is unconscious, it is recommended to turn the person on their side after administering the dose of Baqsimi.1
Enclosed Prescribing Information
1Baqsimi [instructions for use]. Indianapolis, IN: Eli Lilly and Company; 2019.
Date of Last Review: January 14, 2022